IDEXX Laboratories, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 57.35%

IDEXX Laboratories, Inc. Return on Equity (ROE) is 57.35% for the Trailing 12 Months (TTM) ending March 31, 2025, a -9.91% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • IDEXX Laboratories, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 63.66%, a -45.76% change year over year.
  • IDEXX Laboratories, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 117.37%, a 13.13% change year over year.
  • IDEXX Laboratories, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 103.75%, a -21.20% change year over year.
  • IDEXX Laboratories, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 131.66%, a -50.36% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share